Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DVAX

Dynavax

$18.10

-0.6 (-3.21%)

06:39
04/23/18
04/23
06:39
04/23/18
06:39
Hot Stocks
Dynavax announces CDC published ACIP recommendations for HEPLISAV-B »

Dynavax Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

Over a week ago
DVAX

Dynavax

, MRK

Merck

09:22
04/17/18
04/17
09:22
04/17/18
09:22
Hot Stocks
Dynavax provides durability response data for SD-101 with KEYTRUDA »

Dynavax Technologies…

DVAX

Dynavax

MRK

Merck

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 05

    Jun

  • 12

    Jun

  • 23

    Oct

DVAX

Dynavax

$18.85

-0.95 (-4.80%)

09:06
04/17/18
04/17
09:06
04/17/18
09:06
Recommendations
Dynavax analyst commentary at William Blair »

William Blair says SD-101…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

DVAX

Dynavax

$18.85

-0.95 (-4.80%)

08:53
04/17/18
04/17
08:53
04/17/18
08:53
Recommendations
Dynavax analyst commentary at Cowen »

Dynavax shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

DVAX

Dynavax

$19.75

-1 (-4.82%)

, MRK

Merck

$58.48

1.31 (2.29%)

14:15
04/16/18
04/16
14:15
04/16/18
14:15
Hot Stocks
Dynavax reports interim data for study of SD-101 in combination Merck's Keytruda »

Dynavax (DVAX) announced…

DVAX

Dynavax

$19.75

-1 (-4.82%)

MRK

Merck

$58.48

1.31 (2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 20

    Apr

  • 23

    Apr

  • 24

    Apr

  • 26

    Apr

  • 27

    Apr

  • 01

    May

  • 08

    May

  • 05

    Jun

  • 12

    Jun

  • 23

    Oct

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

, BAC

Bank of America

$29.80

-0.85 (-2.77%)

09:06
04/16/18
04/16
09:06
04/16/18
09:06
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Alkermes (ALKS),…

ALKS

Alkermes

$42.53

-0.43 (-1.00%)

BAC

Bank of America

$29.80

-0.85 (-2.77%)

WPP

WPP

$84.53

0.41 (0.49%)

ERI

Eldorado Resorts

$35.70

0.2 (0.56%)

TPCA

Tropicana

ALGT

Allegiant Travel

$151.05

-14.2 (-8.59%)

DVAX

Dynavax

$19.75

-1 (-4.82%)

LOXO

Loxo Oncology

$122.99

-3.25 (-2.57%)

BPMC

Blueprint Medicines

$98.98

-2.2 (-2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 16

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 03

    May

  • 08

    May

  • 21

    May

  • 12

    Jun

DVAX

Dynavax

$19.75

-1 (-4.82%)

08:54
04/16/18
04/16
08:54
04/16/18
08:54
Recommendations
Dynavax analyst commentary at JPMorgan »

Dynavax should be up 35%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

DVAX

Dynavax

$19.75

-1 (-4.82%)

08:48
04/16/18
04/16
08:48
04/16/18
08:48
Hot Stocks
Dynavax abstract shows 40% response rate in head and neck cancer »

In an abstract posted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

ADAP

Adaptimmune

$10.84

-0.21 (-1.90%)

, ADRO

Aduro Biotech

$8.60

-0.3 (-3.37%)

08:07
04/04/18
04/04
08:07
04/04/18
08:07
Conference/Events
William Blair to hold a conference »

Annual Cancer…

ADAP

Adaptimmune

$10.84

-0.21 (-1.90%)

ADRO

Aduro Biotech

$8.60

-0.3 (-3.37%)

AGEN

Agenus

ATRA

Atara Biotherapeutics

$36.25

-0.65 (-1.76%)

BGNE

BeiGene

$165.00

-0.32 (-0.19%)

BLCM

Bellicum Pharmaceuticals

$6.53

0.17 (2.67%)

CALA

Calithera Biosciences

$5.85

-0.5 (-7.87%)

CLLS

Cellectis

$38.53

7.8 (25.38%)

DNA

Bought by RHHBY

DVAX

Dynavax

$18.30

-0.5 (-2.66%)

FATE

Fate Therapeutics

$9.62

0.15 (1.58%)

IDRA

Idera Pharmaceuticals

$1.71

0.09 (5.56%)

INFI

Infinity Pharmaceuticals

$1.96

-0.04 (-2.00%)

IOVA

Iovance Biotherapeutics

$14.50

-1.15 (-7.35%)

LLY

Eli Lilly

$77.54

1.84 (2.43%)

MRK

Merck

$54.09

0.82 (1.54%)

NVS

Novartis

$80.12

0.53 (0.67%)

PIRS

Pieris Pharmaceuticals

$6.55

0.07 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 09

    Apr

  • 14

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 01

    May

  • 07

    May

  • 17

    May

  • 18

    May

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 23

    Oct

  • 05

    Apr

Over a month ago
DVAX

Dynavax

$17.60

0.3 (1.73%)

06:37
03/08/18
03/08
06:37
03/08/18
06:37
Earnings
Dynavax reports Q4 EPS (45c), consensus (33c) »

Reports Q4 revenue $21K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.